Enjoy complimentary customisation on priority with our Enterprise License!
The global gynecological cancers therapeutics market size is estimated to grow by USD 19.15 billion at a CAGR of 15.83% between 2023 and 2028.
The pipeline for treating gynecological cancers is advancing with novel therapeutics, including vaccines, gene therapy, and targeted therapy products. While gene therapy is in early clinical development, targeted therapy and vaccine products are in late stages, with some anticipated to launch in the forecast period. These innovations, employing mechanisms like PD-L1 inhibition, cell cycle inhibition, angiogenesis inhibition, and PARP inhibition, are poised to transform gynecological cancer treatment. Clinical trials predominantly focus on combination therapies, but several companies are dedicated to developing unique targeted therapies. Notably, Atezolizumab and vaccines like Z-100 and an Advaxis therapeutic vaccine, currently in Phase III trials, show promise for cervical cancer treatment. The market is witnessing accelerated approvals, with three PARP inhibitors such as Lynparza, Rubraca, and ZEJULA. Regulatory approvals for drugs like Lynparza and Zejula, particularly for ovarian cancer, indicate a positive trajectory, driving growth in the market during the forecast period.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Modality
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.